Canada Pension Plan Investment Board Tcr2 Therapeutics Inc. Transaction History

Canada Pension Plan Investment Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$20.38 - $34.07 $2.04 Million - $3.41 Million	-100,000 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$19.0 - $32.63 $855,000 - $1.47 Million	45,000 Added 81.82%	100,000 $3.09 Million
Q3 2020 Nov 12, 2020	BUY	$13.1 - $20.69 $720,500 - $1.14 Million	55,000 New	55,000 $1.12 Million
Q4 2019 Feb 14, 2020	SELL	$12.17 - $17.88 $730,200 - $1.07 Million	-60,000 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$10.15 - $19.53 $507,500 - $976,500	50,000 Added 500.0%	60,000 $902,000
Q2 2019 Aug 12, 2019	SELL	$13.64 - $20.97 $272,800 - $419,400	-20,000 Reduced 66.67%	10,000 $143,000
Q1 2019 May 15, 2019	BUY	$15.01 - $22.15 $450,300 - $664,500	30,000 New	30,000 $523,000

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.